HCP, Inc. (NYSE:HCP) had its price target boosted by Barclays PLC from $32.00 to $33.00 in a report released on Tuesday morning. The brokerage currently has an equal weight rating on the real estate investment trust’s stock.

HCP has been the topic of a number of other research reports. Goldman Sachs Group, Inc. (The) upgraded shares of HCP from a neutral rating to a buy rating and boosted their price objective for the company from $29.00 to $35.00 in a research report on Wednesday, January 25th. Vetr cut shares of HCP from a strong-buy rating to a buy rating and set a $32.83 price objective on the stock. in a research report on Tuesday, November 15th. Zacks Investment Research upgraded shares of HCP from a strong sell rating to a hold rating in a research report on Tuesday, January 31st. BTIG Research restated a neutral rating on shares of HCP in a research report on Tuesday, November 1st. Finally, Stifel Nicolaus upgraded shares of HCP from a sell rating to a hold rating and decreased their price objective for the company from $33.00 to $31.00 in a research report on Wednesday, November 2nd. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have issued a buy rating to the company. HCP currently has a consensus rating of Hold and an average target price of $33.35.

Analyst Recommendations for HCP (NYSE:HCP)

HCP (NYSE:HCP) opened at 30.98 on Tuesday. The company has a market cap of $14.50 billion, a PE ratio of 23.14 and a beta of 0.27. HCP has a 52-week low of $25.22 and a 52-week high of $36.82. The stock’s 50 day moving average is $30.38 and its 200-day moving average is $32.02.

HCP (NYSE:HCP) last issued its earnings results on Monday, February 13th. The real estate investment trust reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.02. HCP had a net margin of 25.10% and a return on equity of 6.51%. The company had revenue of $540 million for the quarter, compared to analysts’ expectations of $527.10 million. During the same quarter last year, the company earned $0.80 EPS. The firm’s revenue was up 3.8% compared to the same quarter last year. Equities research analysts predict that HCP will post $0.82 EPS for the current fiscal year.

This piece of content was originally published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another domain, it was copied illegally and republished in violation of international copyright law. The legal version of this piece of content can be viewed at http://www.dailypolitical.com/2017/02/17/hcp-inc-hcp-price-target-raised-to-33-00.html.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 2nd. Investors of record on Wednesday, February 15th will be paid a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a yield of 4.78%. The ex-dividend date of this dividend is Monday, February 13th. HCP’s payout ratio is currently 111.28%.

A number of large investors have recently bought and sold shares of the company. Hanlon Investment Management Inc. acquired a new stake in HCP during the second quarter valued at approximately $4,763,000. Vicus Capital raised its stake in HCP by 6.3% in the second quarter. Vicus Capital now owns 7,067 shares of the real estate investment trust’s stock valued at $250,000 after buying an additional 416 shares during the last quarter. Quantbot Technologies LP raised its stake in HCP by 203.5% in the second quarter. Quantbot Technologies LP now owns 188,611 shares of the real estate investment trust’s stock valued at $6,673,000 after buying an additional 126,459 shares during the last quarter. Foster & Motley Inc. raised its stake in HCP by 8.1% in the second quarter. Foster & Motley Inc. now owns 40,776 shares of the real estate investment trust’s stock valued at $1,443,000 after buying an additional 3,062 shares during the last quarter. Finally, ProVise Management Group LLC acquired a new stake in HCP during the second quarter valued at approximately $3,140,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.

HCP Company Profile

HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.

5 Day Chart for NYSE:HCP

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.